Infinity to Present at 37th Annual Cowen and Company Healthcare Conference

Monday, February 27, 2017 Women Health News
Email Print This Page Comment
Font : A-A+

CAMBRIDGE, Mass., Feb. 27, 2017 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the Cowen

and Company 37th Annual Healthcare Conference on Monday, March 6, 2017, at 4:00 p.m. ET in Boston, MA. A live webcast of Infinity's presentation will
be accessible on the Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event.

About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1 study in patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.

Contact:Jaren Irene Madden, Senior Director, Investor Relations and Corporate Communications617-453-1336 or Jaren.Madden@infi.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/infinity-to-present-at-37th-annual-cowen-and-company-healthcare-conference-300413327.html

SOURCE Infinity Pharmaceuticals, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook